XTX Markets’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

XTX Markets’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$253K	Buy	+26,209	New	+$251K	0.52%	80

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $4.81B AUM 10.43% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return

XTX Markets's TEVA Position: Q4 2020 in Review

XTX Markets opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q4 2020: 26,209 shares worth $253K. The stake represents 0.52% of the portfolio and ranks #80 among its holdings.

450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

XTX Markets held 26,209 shares of Teva Pharmaceutical Industries Limited worth $253K as of Q4 2020.
Teva Pharmaceutical Industries Limited was a new XTX Markets position in Q4 2020.
Teva Pharmaceutical Industries Limited made up 0.52% of XTX Markets's portfolio in Q4 2020, its #80 holding.
450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.